The DOI matches its Crossref record; 149 of the 150 references it cites were found in a registry or an index.
The molecular bases of Alzheimer’s disease and other neurodegenerative disorders
Open accessAbstract
Alzheimer's disease, the cause of one of the most common types of dementia, is a brain disorder affecting the elderly and is characterized by the formation of two main protein aggregates: senile plaques and neurofibrillary tangles, which are involved in the process leading to progressive neuronal degeneration and death. Neurodegeneration in Alzheimer's disease is a pathologic condition of cells rather than an accelerated way of aging. The senile plaques are generated by a deposition in the human brain of fibrils of the beta-amyloid peptide (Abeta), a fragment derived from the proteolytic processing of the amyloid precursor protein (APP). Tau protein is the major component of paired helical filaments (PHFs), which form a compact filamentous network described as neurofibrillary tangles (NFTs). Experiments with hippocampal cells in culture have indicated a relationship between fibrillary amyloid and the cascade of molecular signals that trigger tau hyperphosphorylations. Two main protein kinases have been shown to be involved in anomalous tau phosphorylations: the cyclin-dependent kinase Cdk5 and glycogen synthase kinase GSK3beta. Cdk5 plays a critical role in brain development and is associated with neurogenesis as revealed by studies in brain cells in culture and neuroblastoma cells. Deregulation of this protein kinase as induced by extracellular amyloid loading results in tau hyperphosphorylations, thus triggering a sequence of molecular events that lead to neuronal degeneration. Inhibitors of Cdk5 and GSK3beta and antisense oligonucleotides exert protection against neuronal death. On the other hand, there is cumulative evidence from studies in cultured brain cells and on brains that oxidative stress constitutes a main factor in the modification of normal signaling pathways in neuronal cells, leading to biochemical and structural abnormalities and neurodegeneration as related to the pathogenesis of Alzheimer's disease. This review is focused on the main protein aggregates responsible for neuronal death in both sporadic and familial forms of Alzheimer's disease, as well as on the alterations in the normal signaling pathways of functional neurons directly involved in neurodegeneration. The analysis is extended to the action of neuroprotective factors including selective inhibitors of tau phosphorylating protein kinases, estrogens, and antioxidants among other molecules that apparently prevent neuronal degeneration.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“NTFs contain, as their first component, aggregates of the protein tau (τ) in a hyperphosphorylated state.”
From Multi-Target Mechanisms of Phytochemicals in Alzheimer’s Disease: Effects on Oxidative Stress, Neuroinflammation and Protein Aggregation (2022) · cites this paper as [19]
In the citing paper
“in healthy neuronal cells, following consecutive and reversible enzymatic processes of phosphorylation and dephosphorylation, it has the task of assembling and stabilizing microtubules and determining their binding with other components of the cytoskeleton [19,20].”
From Multi-Target Mechanisms of Phytochemicals in Alzheimer’s Disease: Effects on Oxidative Stress, Neuroinflammation and Protein Aggregation (2022) · cites this paper as [19]
Citations
Cites
Corder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Small, G. W., Roses, A. D., Haines, J. L., & Pericak-Vance, M. A. (1993) · Science · doi:10.1126/science.8346443 · Cited by 9,429
Rosen, D. R., Siddique, T., Patterson, D., Figlewicz, D. A., Sapp, P., Hentati, A., Donaldson, D., Goto, J., O'Regan, J. P., Deng, H.-X., et al. (1993) · Nature · doi:10.1038/362059a0 · Cited by 7,062
Alzheimer's Disease: Genes, Proteins, and Therapy
Selkoe, D. J. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.2.741 · Cited by 6,063
Glenner, G. G., & Wong, C. W. (1984) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(84)80190-4 · Cited by 5,404
The Release of Cytochrome c from Mitochondria: A Primary Site for Bcl-2 Regulation of Apoptosis
Kluck, R. M., Bossy‐Wetzel, E., Green, D. R., & Newmeyer, D. D. (1997) · Science · doi:10.1126/science.275.5303.1132 · Cited by 4,715
The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor
Kang, J., Lemaire, H.-G., Unterbeck, A., Salbaum, J. M., Masters, C. L., Grzeschik, K.-H., Multhaup, G., Beyreuther, K., & Müller-Hill, B. (1987) · Nature · doi:10.1038/325733a0 · Cited by 4,619
Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease
Sherrington, R., Rogaev, E. I., Liang, Y., Rogaeva, E. A., Levesque, G., Ikeda, M., Chi, H., Lin, C., Li, G., Holman, K., et al. (1995) · Nature · doi:10.1038/375754a0 · Cited by 4,051
Oxidative Stress, Glutamate, and Neurodegenerative Disorders
Coyle, J. T., & Puttfarcken, P. (1993) · Science · doi:10.1126/science.7901908 · Cited by 3,762
Excitatory Amino Acids as a Final Common Pathway for Neurologic Disorders
Epstein, F. H., Lipton, S. A., & Rosenberg, P. A. (1994) · New England Journal of Medicine · doi:10.1056/nejm199403033300907 · Cited by 2,676
Regulation of neuronal survival by the serine-threonine protein kinase Akt
Dudek, H., Datta, S. R., Franke, T. F., Birnbaum, M. J., Yao, R., Cooper, G. M., Segal, R. A., Kaplan, D. R., & Greenberg, M. E. (1997) · Science · doi:10.1126/science.275.5300.661 · Cited by 2,436
Research works printed but not linked: 2
- Catania, 2001, Expression and localization of cyclin-dependent kinase 5 in apoptotic human glioma cells, Neurooncology, 3, 89
- Saez, 1990, Gap junctions, In Vitro Toxicol, 3, 69
Cited by
Sorted by citations
Items 401–477 of 477
Ahmad, W. (2017) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/228437 · Cited by 1
Self-representations: Alterations in frontotemporal lobar degeneration and correlates in the brain
Sturm, V. E. (2009) · eScholarship (California Digital Library)
González, M. C. (2013) · Gredos (University of Salamanca) · doi:10.14201/gredos.122909
Torres, C. A. (2010) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.5.2010.tde-12032010-143731
Torres-Pacheco, L. H. L. (2009) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.9.2009.tde-16092009-150022
Cracchiolo, J. R. (2005) · Digital Commons - University of South Florida (University of South Florida)
Villarreal, A. E., Gómez, L. A., Grajales, S. A., Arrue, R., Carrillo-Pujol, G., Ferro, F., Rao, K. S. J., & Britton, G. B. (2014) · doi:10.3926/oms.55
Barton, J. R. (2011) · Digital Commons - PCOM (Philadelphia College of Osteopathic Medicine)
Alzheimer's disease : a neurodegenerative disease : an honors thesis (HONRS 499)
McCormick, K. I. (2008) · Cardinal Scholar (Ball State University)
Estudio de las vías de supervivencia y muerte neuronal en modelos de la enfermedad de Huntington
Rubia, P. P. (2010) · Tesis Doctorals en Xarxa (Consorci de Serveis Universitaris de Catalunya)
Is anti-cyclic citrullinated Peptide antibody a good value biomarker for Alzheimer disease?
Meamar, R., Askari, G., Ghasemi, M., Ghazvini, M. R. A., Vesal, S., Sharifkhah, M., Faradonbeh, N. A., & Dehghani, L. (2013) · Europe PMC (PubMed Central)
The Significance of Age-Related Androgen Depletion in Cognitive Impairment: A Review
Burkhardt, M. S., Foster, J. K., & Martins, R. N. (2004) · Brain Impairment · doi:10.1375/brim.5.2.166.58254
Uso das estatinas na Doença de Alzheimer: uma revisão
da Silva, A. F., Girardi, J. M., & Raposo, N. R. B. (2011) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Vasoactive Neuropeptides in Autoimmune Diseases
Brenu, E. W., Tajouri, L., Staines, D., & Marshall-Gradisnik, S. M. (2011) · InTech eBooks · doi:10.5772/20940
Function and pathology of the human retinal pigment epithelium
Booij, J. C. (2010) · UvA-DARE (University of Amsterdam)
Aoyama, N. (2011) · Scholarship@Western (Western University)
Presenilin signalling in a basic biomedical model
Ludtmann, M. H. R. (2012)
Physiological roles of Hirano bodies
Ha, S. (2008)
Schuck, P. F. (2005) · Americanae (AECID Library)
Morrison, J. (2015) · UWSpace (University of Waterloo)
Singh, A. K., Gupta, S., Jiang, Y., Younus, M., & Ramzan, M. (2009)
Esch, T., Stefano, G. B., Fricchione, G. L., Benson, H., & Ma, B. (2002)
Estatinas: efeitos pleiotrópicos. Statins: pleiotropic effects
Machado, W. M., Munhoz, A. C. M., & Fernandes, D. (2011) · Publicatio UEPG Ciencias Biologicas e da Saude · doi:10.5212/publ.biologicas.v.17i2.0008
Medicinal ChemistryApproaches for theTreatment and Prevention of Alzheimer's Disease
Бачурин, С. О. (2003)
Gárdián, G., Sas, K., Toldi, J., & Vécsei, L. (2009) · doi:10.1093/acprof:oso/9780195326697.003.0018
Butzlaff, M. (2011) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-1007
Unravelling the genetic components of late onset Alzheimer's disease.
Hamilton, G. (2005) · OpenGrey (Institut de l'Information Scientifique et Technique)
Identifying the mechanism of Aβ42 inhibition of PDGF-BB signalling
Saffi, G. T. (2014) · UWSpace (University of Waterloo)
Hormonal and non-hormonal factors associated with cognition in post-menopausal women
Rodrigues, M. A. (2004) · UWA Profiles and Research Repository (UWA)
3-Phenylpyrazino[1,2-a]indol-1(2H)-ones as dual cholinesterase and amyloid aggregation inhibitors
Gujral, S. S. (2017) · UWSpace (University of Waterloo)
Bielefeld, P., Pustjens, B., Schouten, M., & Fitzsimons, C. P. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804402-5.00009-1
Neurochemical Aspects of β-Amyloid Cascade Hypothesis for Alzheimer’s Disease
Farooqui, A. A. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-809937-7.00001-x · Cited by 1
Emotional Gaze in Frontotemporal Lobar Dementia
Yuan, J. W. (2009) · eScholarship (California Digital Library)
IDENTIFICATION OF NOVEL SUBSTRATES OF LRRK2, A PARKINSON’S DISEASE ASSOCIATED KINASE
Lee, C. H. (2014) · OhioLink ETD Center (Ohio Library and Information Network)
Bakir, I. (2010) · KTH Publication Database DiVA (KTH Royal Institute of Technology)
Molina, V., Sanz, J., Sarramea, F., Misiego, J. M., Carlos Benito, C., & Palomo, T. (2005) · European psychiatry (Ed Española) · doi:10.1017/s1134066500004033
[Disruption of iron homeostasis and relevant pharmacotherapies in Alzheimer’s disease].
Zhao, X.-Y., Wang, Y., Wang, G., & Zhang, J.-J. (2016) · PubMed
The Metabolic Relationship between Type 2 Diabetes and Alzheimer's Disease
Ayala, D. (2019) · UA Campus Repository (The University of Arizona)
Classification of Protein Modification Sites with Machine Learning
Sun, J., Bao, W., Cao, Y., & Chen, Y. (2020) · Lecture notes in computer science · doi:10.1007/978-3-030-60802-6_38
CirBiTree: Citrullination Site Inference Based on a Fuzzy Neural Network and Flexible Neural Tree
Song, C., & Wang, H. (2020) · Scientific Programming · doi:10.1155/2020/8847694
Vitamin E in Disease Prevention and Therapy
a, U. O.-J., & a, L. P. (2003) · AOCS Publishing eBooks · doi:10.1201/9781439822173.ch19
Rosenzweig, S. A. (2020) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.735351451.793572343
Phytocongress Sastra University (2017) · Asian Journal of Pharmaceutical and Clinical Research · doi:10.22159/ajpcr.2017.v10i2.17793
Lateral flow assay for early diagnosis of neurodegenerative disorder
Kumawat, T. K., Parihar, A., Kumawat, V., Sharma, V. L., Pandit, A., Sharma, B., & Biyani, M. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-95539-3.00013-2
Ezejindu, D. N., & Udodi, P. S. (2023) · NIgerian Journal of Neuroscience · doi:10.47081/njn2023.14.3/001
Neuroprotective efficacy of melatonin in the pathophysiology of neurodegenerative disorders
Tasleem, A., Kaushik, M., Kaushik, P., Tabassum, H., & Parvez, S. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-23763-8.00062-2
Mass Spectrometry-Based Metabolomics Multi-platform for Alzheimer’s Disease Research
González‐Domínguez, Á., Sayago, A., Fernández‐Recamales, Á., & González‐Domínguez, R. (2024) · Methods in molecular biology · doi:10.1007/978-1-0716-3774-6_6
Determination of Alzheimer’s Drugs in a Human Urine Sample by Different Chemometric Methods
ERTOKUŞ, G. P. (2024) · International Journal of Analytical Chemistry · doi:10.1155/2024/5535816
Effects of melatonin on neurodegeneration
Atukeren, P. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-30240-4.00009-0
Prevention of Brain Disorders by Nicotine
Alkadhi, K. A., Salim, S., & Alzoubi, K. H. (2013) · Springer eBooks · doi:10.1007/978-3-642-22144-6_178
González‐Domínguez, Á., Jurado‐Sumariva, L., Sayago, A., Schwarz, M., Fernández‐Recamales, Á., Durán, E., & González‐Domínguez, R. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-19116-9.00012-9
Vinutha, A. S., Akshay, S., Agash, S. G. S., Chandrasekhar, G., Bhattacharya, A., & Rajasekaran, R. (2026) · Archives of Microbiology · doi:10.1007/s00203-026-04797-7
Descamps, A. (2009) · theses.fr (ABES) · doi:10.70675/b1d785e5zdc1az4353z958czf0e16102bc0d
Patricio-Martínez, A., Patricio, F., Pérez, I. E., Martínez, I., Alemán-Alemán, V., Aguilera, J., & Limón, I. D. (2026) · Neuroscience · doi:10.1016/j.neuroscience.2026.07.019
Feature-Level Fusion of EEG and MRI for Robust Multimodal Alzheimer’s Disease Classification
Anand, K., & Kumar, N. (2026) · International Conference on Secure Cyber Computing and Communications (ICSCCC) · doi:10.1109/icsccc69031.2026.11600001
Shukla, A. K., Cho, W., Ahn, M., Shukla, S., Upadhyay, A. M., Nagappan, A., Mongre, R. K., & Kim, B. S. (2026) · Bioprinting · doi:10.1016/j.bprint.2026.e00497
Pan, N., Cao, P., Zhang, C., Wu, F., & Ning, Y. (2026) · Journal of Alzheimer s Disease Reports · doi:10.1177/25424823261483598
Detection of small discrete 5'-terminal fragments of 18S rRNA in mouse cells
Malysheva, A. A., Kazanbassov, T. S., Lopatchenko, T., Osikova, K. G., Iskakov, B. K., & Zhigailov, A. V. (2026) · Fundamental and Experimental Biology · doi:10.31489/2026feb3/201-210
Saini, A., Kumar, D., Agrawal, M., Singh, A., Manda, R. M., Yadav, M., Kumar, P., & Kumar, M. (2026) · Pharmacological Research - Modern Chinese Medicine · doi:10.1016/j.prmcm.2026.100888
BindingDB Entry 50024284: Effects of natural flavones and flavonols on the kinase activity of Cdk5.
BindingDB (2010) · UC San Diego · doi:10.7270/q2zp45wf
BindingDB (2010) · UC San Diego · doi:10.7270/q2qn66xj
Ribeiro, C. A. J. (2006) · Americanae (AECID Library)
TRIPTOLIDE IS A POTENTIAL THERAPEUTIC AGENT FOR ALZHEIMER'S DISEASE
Allsbrook, M. (2009) · VCU Scholars Compass (Virginia Commonwealth University) · doi:10.25772/94wv-p926
Metadata
- Authors
- Maccioni, R. B., Muñoz, J. P., & Barbeito, L.
- Affiliations
- University of Chile (CL)
- Instituto de Investigaciones Biológicas Clemente Estable (UY)
- Corresponding author
- Maccioni, Ricardo B
- Venue
- Archives of Medical Research
- Publisher
- Elsevier BV
- Published
- 2001-09
- Volume
- 32
- Issue
- 5
- Pages
- 367-381
- ISSN
- 0066-6769 (ISSN-L)
- 0188-4409
- OpenAlex
- W1985122965
- Cited by
- 474
- References
- 150
- Citations by year
- 2026: 8 · 2025: 12 · 2024: 24 · 2023: 8 · 2022: 13 · 2021: 14 · 2020: 17 · 2019: 19 · 2018: 20 · 2017: 28 · 2016: 17 · 2015: 17 · 2014: 19 · 2013: 22 · 2012: 30
- FWCI
- 2.49
- Type
- journal article
- Language
- en
- Open access
- green
- americanae.aecid.es
- Licence
- Locations
- Archives of Medical Research (publishedVersion)
- PubMed (publishedVersion)
- Americanae (AECID Library) (submittedVersion, other-oa)
- LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (submittedVersion, other-oa)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- Alzheimer's disease, neurodegeneration, amyloid plaques, neurofibrillary tangles, amyloid-beta, amyloid precursor protein, tau protein, tau hyperphosphorylation, cyclin-dependent kinase 5, GSK3β, oxidative stress, neuronal cell death, neuroprotective factors, estrogen, antioxidants, protein kinase inhibitors, antisense oligonucleotides, dementia
- MeSH terms
- Adult, Aged, alpha-Macroglobulins, Alzheimer Disease, Amino Acid Sequence, Apolipoproteins E, Astrocytes, Calcium, Estrogens, Humans, Membrane Proteins, Memory Disorders, Middle Aged, Molecular Sequence Data, Nerve Tissue Proteins, Neurons, Neurotoxins, Nitric Oxide, Parkinson Disease, Protein Processing, Post-Translational, Signal Transduction, Motor Neuron Disease, Amyloid beta-Protein Precursor, Neurofibrillary Tangles, tau Proteins, Cell Death, Age of Onset, Oxidative Stress, Neurodegenerative Diseases, Caspases, Presenilin-1, Presenilin-2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review